CASI Pharmaceuticals - CASI Earnings per share for the last twelve months

CASI Pharmaceuticals maintains a high authority in oncohematology and strong physician trust, ensuring stable growth. The rolling net income per share chart visualizes this success, where -3.02 serves as the parameter's baseline value. Business efficiency is bolstered by the licensing of Western drugs for China, which minimizes R&D risks, as well as strict adherence to ESG standards regarding hazardous waste disposal and eco-packaging.

CASI CASI Pharmaceuticals, Inc Net earnings per one share for the last twelve months (07/04/2022 - 03/14/2026)

CASI (CASI Pharmaceuticals Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:

Price Chart CASI Pharmaceuticals, Inc|CASI - Price Target Chart

- issuer market value details:

Market Value CASI Pharmaceuticals, Inc.|CASI - Total Enterprise Value

- shareholders' equity book value data:

Net Assets per Single Share CASI Pharmaceuticals|CASI - Total Stockholders' Equity|Market Capitalization to Book Value Ratio casipharmaceuticals.com|CASI - Total Business Assets

- debt and liquidity details:

Total Debt to Capital CASI Pharmaceuticals|CASI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital CASI Pharmaceuticals, Inc|CASI - Company Aggregate Debts|Debt to Book Capitalization Ratio CASI Pharmaceuticals, Inc.|CASI - Long-Term Debt Volume|Company Short-Term Debts CASI Pharmaceuticals|Quick Liquidity Indicator casipharmaceuticals.com

- earnings and multiples data:

CASI - Final Profit|Expected Profit CASI Pharmaceuticals|CASI - Market Cap to Net Income|Forward P/E Multiple CASI Pharmaceuticals, Inc|CASI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CASI Pharmaceuticals, Inc.|CASI - Operating profit EBITDA|Earnings per share for the last twelve months CASI Pharmaceuticals|CASI - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months casipharmaceuticals.com|CASI - Net earnings per share growth this year|Earnings growth forecast for next year CASI Pharmaceuticals

Analysis of all company metrics:CASI - casipharmaceuticals.com

Manufactured products of CASI Pharmaceuticals Inc.

Investors seek a fundamental anchor in profit generation efficiency. For CASI Pharmaceuticals (CASI), high expansion costs in China temporarily exceed revenue, creating a liquidity deficit. This rolling net income per share snapshot measures the final income allocated to a single share per year. Positive momentum in this metric confirms business resilience, while a decline in the indicator signals risks of overpaying for the asset.

Competitors of CASI Pharmaceuticals